NCT04726098View on ClinicalTrials.gov

Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19

PHASE4CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Covid19Corticosteroids
Interventions
DRUG

Dexamethasone high dose

High doses: dexamethasone 20 mg/day 5 days + 10 mg/day 5 days (total 10 days)

DRUG

Dexamethasone low dose

Low doses: dexamethasone 6 mg/day 10 days.

Trial Locations (1)

15866

University Clinical Hospital of Santiago de Compostela, Santiago de Compostela

All Listed Sponsors
lead

Manuel Taboada Muñiz

OTHER

NCT04726098 - Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19 | Biotech Hunter | Biotech Hunter